课题基金 / 基金详情

Elucidation of activation mechanism of MN/CA9 in human renal cell carcinomas

Elucidation of activation mechanism of MN/CA9 in human renal cell carcinomas
阐明 MN/CA9 在人肾细胞癌中的激活机制
批准号:
11670224
负责人:
CHO Masaki
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
MN/CA 9基因5 '端低甲基化与肾癌组织中MN/CA 9表达的相关性MN/CA 9基因5'端-74bp的CpG低甲基化与肾癌细胞系和肾癌组织中MN/CA 9的表达密切相关。通过亚硫酸氢盐基因组测序方案检查甲基化状态。用5-氮杂-2 ′-脱氧胞苷(5-aza-2 ′-deoxycytidine)处理MN/CA 9阴性肾癌细胞系,可激活MN/CA 9基因,并鉴定MN/CA 9启动子区。体外DNA甲基化对MN/CA 9启动子活性的影响将MN/CA 9启动子(-158 / +42 bp)/荧光素酶报告质粒分别用CpG甲基化酶(SssI或HhaI)处理,转染MN/CA 9阳性肾癌细胞系。MN/CA 9启动子的所有CpG均被SssI甲基化,仅-74bp处的CpG被HhaI特异性甲基化,SssI和HhaI均能抑制MN/CA 9启动子的活性,提示MN/CA 9启动子-74bp处的CpG低甲基化可能在人肾癌MN/CA 9表达中起重要作用。
英文摘要
Correlation between MN/CA9 expression and hypomethylation of MN/CA9 5'flanking region in human renal cell carcinomasHypomethylation of the CpG at -74 bp of MN/CA9 was strongly correlated with MN/CA9 expression in both human renal cell carcinoma (RCC) cell lines and human RCC tissues. Methylation status was examined by bisulfite genomic sequencing protocol. MN/CA9 expression was examined by RT-PCR.Induction of MN/CA9 expression by treatment with a demethylating agentTreatment with the demethylating agent 5-aza-2'-deoxycytidine resulted in activation of the MN/CA9 gene in MN/CA9 negative RCC cell lines.Identification of MN/CA9 promoter regionDNAs of MN/CA9 5' flanking region (-1246 / +42 bp) were ligated into luciferase reporter plasmids. Deletion analyses revealed that 5' end of minimal MN/CA9 promoter was located between -158 bp and -58 bp.Effect of in vitro DNA methylation on promoter activityMN/CA9 promoter (-158 / +42 bp) / luciferase reporter plasmids were treated with CpG methylases (SssI or HhaI) and transfected into MN/CA9 positive RCC cell lines. All CpGs of MN/CA9 promoter were methylated by SssI, and only CpG at -74 bp was specifically methylated by HhaI.Activity of MN/CA9 promoter was strongly suppressed by treatment with both SssI and HhaI.These data suggest that hypomethylation of the CpG at -74bp in MN/CA9 promoter may have a major role in MN/CA9 expression in human renal cell carcinomas.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
Uemura, H., Nakagawa, Y., Hirao, Y., Okajima, E., Yoshikawa, K., Oosterwijk, E.: "Expression of MN antigen in urologic cancer : potential tool as a therapeutic target."Aktuel Urology. 31. 52-54 (2000)
Uemura, H.、Nakakawa, Y.、Hirao, Y.、Okajima, E.、Yoshikawa, K.、Oosterwijk, E.:“泌尿系统癌症中 MN 抗原的表达:作为治疗靶点的潜在工具。”Aktuel Urology。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Cho M: "Activation of the MN/CA9 gene is associated with hyponethylation in human venal cell carcinomas cell lines"Molecular Carcinogenesis. 27(3). 184-189 (2000)
Cho M:“MN/CA9 基因的激活与人静脉细胞癌细胞系中的低甲基化有关”分子癌发生。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Uemura H: "MN/CA IX/G250 as a potential target for immuno-therapy of renal cell carcinoma"British Journal of Cancer. 81. 741-746 (1999)
Uemura H:“MN/CA IX/G250 作为肾细胞癌免疫治疗的潜在靶点”英国癌症杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 19 条
    国内基金
    海外基金
    新型生物α-Mn2O3酶促合成及其新污染物高级氧化研究
    • 批准号:
      2026JJ80061
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      李丁
    • 依托单位:
    3D打印Fe/Mn双组分多层孔道电极电化学靶向回收浮选复合废水中Sb(V)的机理研究
    • 批准号:
      2026JJ50213
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      侯保林
    • 依托单位:
    尖晶石型Li₁.₃₃Mn₁.₆₇O₄中Li⁺/H⁺界面交换动力学机理与锰溶损靶向钝化机制研究
    高效全天候催化体系处理核电厂有机废液中51Cr/54Mn的机制研究
    • 批准号:
      2026JJ80233
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谢超
    • 依托单位: